Age-related alteration of arginase activity impacts on severity of leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 2, Issue 5, 2008, Pages

  Müller, Ingrid ^a   Hailu, Asrat ^b   Choi, Beak San ^a   Abebe, Tamrat ^b   Fuentes, Jose M ^c   Munder, Markus ^d   Modolell, Manuel ^e   Kropf, Pascale ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c UNIVERSITY OF EXTREMADURA   (Spain)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 1; ARGININE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; ENDEMIC DISEASE; ENZYME ACTIVITY; ETHIOPIA; FEMALE; HELPER CELL; HUMAN; INFECTION RATE; INTRACELLULAR KILLING; JUVENILE ANIMAL; LEISHMANIASIS; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MICROBIAL GROWTH; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKIN LEISHMANIASIS; UPREGULATION; VISCERAL LEISHMANIASIS; AGE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; MACROPHAGE; METABOLISM; PARASITOLOGY; WESTERN BLOTTING;

AGE DISTRIBUTION; AGE FACTORS; ANIMALS; ARGINASE; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; FLOW CYTOMETRY; LEISHMANIASIS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; MICE, INBRED BALB C;

EID: 48949118033     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000235     Document Type: Article

References (53)

1. Desjeux P (1999) Global control and Leishmania HIV co-infection. Clin Dermatol 17: 317-325.
2. Evans TG, Teixeira MJ, McAuliffe IT, Vasconcelos I, Vasconcelos AW, et al. (1992) Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 166: 1124-1132.
3. Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, et al. (1986) A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154: 639-649.
4. Velo E, Bino S, Kuli-Lito G, Pano K, Gradoni L, et al. (2003) Recrudescence of visceral leishmaniasis in Albania: retrospective analysis of cases during 1997 to 2001 and results of an entomological survey carried out during 2001 in some districts. Trans R Soc Trop Med Hyg 97: 288-290.
5. Alborzi A, Rasouli M, Shamsizadeh A (2006 Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Am J Trop Med Hyg 74: 306-307.
6. Marlet MV, Wuillaume F, Jacquet D, Quispe KW, Dujardin JC, et al. (2003) A neglected disease of humans: a new focus of visceral leishmaniasis in Bakool, Somalia. Trans R Soc Trop Med Hyg 97: 667-671.
7. Marlet MV, Sang DK, Ritmeijer K, Mugsa RO, Onsongo J, et al. (2003) Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. Trans R Soc Trop Med Hyg 97: 515-518.
8. Tanir G, Taylan Ozkan A, Daglar E (2006) Pediatric visceral Leishmaniasis in Turkey. Pediatr Int 48: 66-69.
9. Ryan JR, Mbui J, Rashid JR, Wasunna MK, Kirigi G, et al. (2006) Spatial clustering and epidemiological aspects of visceral leishmaniasis in two endemic villages, Baringo District, Kenya. Am J Trop Med Hyg 74: 308-317.
10. Abdeen ZA, Sawalha SS, Eisenberger CL, Khanfar HM, Greenblatt CL, et al. (2002) Epidemiology of visceral leishmaniasis in the Jenin District, West Bank: 1989-1998. Am J Trop Med Hyg 66: 329-333.
11. Sacks DL, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nature Review Immunol 2: 845-858.
12. Anderson CF, Oukka M, Kuchroo VJ, Sacks D (2007) CD4(+)CD25(-) Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204: 285-297.
13. Noben-Trauth N, Kropf P, Müller I (1996) Susceptibility to Leishmainia major infection in interleukin-4 deficient mice. Science 271: 987-990.
14. Modolell M, Corraliza IM, Link F, Soler G, Eichmann K (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 25: 1101-1104.
15. Wei Y, Charles IG, Smith A, Ure J, Freng G, et al. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411.
16. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, et al. (2002) IL-4 dependent alternatively-activated macrophagrs have a distinctive in vivo gene expression phenotype. BMC Immunology 3: 7.
17. Gordon S (2003) Alternative activation of macrophages. Nature Reviews Immunology 3: 23-35.
18. Wu G, Morris SM Jr (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336 (Pt 1): 1-17.
19. Cederbaum SD, Yu H, Grody WW, Kern RM, Yon P, et al. (2004) Arginases I and II: do their functions overlap? Mol Gen Metabol 81: S38-S44.
20. Kropf P, Fuentes JM, Fahnrich E, Arpa L, Herath S, et al. (2005) Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. Faseb J 19: 1000-1002.
21. Hailu A, Menon JN, Berhe N, Gedamu L, Hassard TH, et al. (2001) Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure. J Infect Dis 184: 112-115.
22. Kropf P, Brunson K, Etges R, Müller I (1998) The Leishmaniasis Model. Immunology of Infection. 1st edition ed. San Diego: Academic Press. pp 419-458.
23. Glaser TA, Wells SJ, Spithill TW, Pettitt JM, Humphris DC, et al. (1990) Leishmania major and L. donovani: a method for rapid purification of amastigotes. Exp Parasitol 71: 343-345.
24. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, et al. (1999) Th1/ Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 163: 3771-3777.
25. Kropf P, Herath S, Tewari R, Syed N, Klemenz R, et al. (2002) Identification of two distinct subpopulations of Leishmania major specific T helper 2 cells. Infect Immun 70: 5512-5520.
26. Herath S, Kropf P, Müller I (2003) Cross-talk between CD8+ and CD4+ T tells in experimental cutaneous leishmaniasis: CD8+ T cells are required for optimal IFN-g production by CD4+ T cells. Parasite Immunol. pp 559-567.
27. Fulford AJ, Webster M, Ouma JH, Kimani G, Dunne DW (1998) Puberty and Age-related Changes in Susceptibility to Schistosome Infection. Parasitol Today 14: 23-26.
28. Fuller A, Yahikozawa H, So EY, Dal Canto M, Koh CS, et al. (2007) Castration of male C57L/J mice increases susceptibility and estrogen treatment restores resistance to Theiler's virus-induced demyelinating disease. J Neurosci Res 85: 871-881.
29. Borges-Walmsley MI, Chen D, Shu X, Walmsley AR (2002) The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol 10: 80-87.
30. Sugiura K, Nishikawa, M, Ishiguro K, Tajima T, Inaba M, et al. (2004) Effect of ovarian hormones on periodical changes in immune resistance associated with estrous cycle in the beagle bitch. Immunobiology 209: 619-627.
31. Pung OJ, Tucker AN, Vore SJ, Luster MI (1985) Influence of estrogen on host resistance: increased susceptibility of mice to Listeria monocytogenes correlates with depressed production of interleukin 2. Infect Immun 50: 91-96.
32. Kropf P, Herath S, Weber V, Modolell M, Müller I (2003) Factors influencing Leishmania major infection in IL-4 deficient BALP/c mice. Parasite Immunol 25: 439-447.
33. Roberts SC, Tancer MJ, Polinsky MR, Gibson KM, Heby O, et al. (2004) Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania: Characterization of gene deletion mutants. J Biol Chem; in press, M402042200.
34. Iniesta V, Gomez-Nieto LC, Molano I, Mohedano A, Carcelen J, et al. (2002) Arginase I induction in macrophages, triggered by Th2-type cytokines supports the growth of intracellular Leishmania parasites. Parasite Immunol 24: 113-118.
35. Kepka-Lenhart D, Mistry SK, Wu G, Morris SM (2000) Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages? Am J Physiol Regulatory Integrative Comp Physiol 279: R2237-R2242.
36. Fligger J, Blum J, Jungi TW (1999) Induction of intracellular arginase activity does not diminish the capacity of macrophages to produce nitric oxide in vitro. Immunobiology 200: 169-186.
37. Gaur U, Roberts SC, Dalvi RP, Corraliza I, Ullman B, et al. (2007) An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. J Immunol 179: 8446-8453.
38. Haynes I, Swain SL (2006) Why aging T cells fail: implications for vaccination. Immunity 24: 663-666.
39. Bender BS, Tallman E (1992) The heterogeneity of the age-related decline in immune response: impairment in delayed-type hypersensitivity and cytatoxic T-lymphocyte activity occur independently. Exp Gerontol 27: 347-354.
40. Marin VB, Rodriguez-Osiac L, Schlessinger L, Villegas J, Lopez M, et al. (2006) Controlled study of enteral arginine supplementation in burned children: impact on immunologic and metabolic status. Nutrition 22: 705-712.
41. Albina JE, Mills CD, Henry WI, Jr, Caldwell MD (1990) Temporal expression of different pathways of 1-arginine, metabolism in healing wounds. J Immunol 144: 3877-3880.
42. Curran JN, Winter DC, Bouchier-Hayes D (2006) Biological fate and clinical implications of arginine metabolism in tissue healing. Wound Repair Regen 14: 376-386.
43. Humphreys NE, Grencis RK (2002) Effects of ageing on the immunoregulation of parasitic infection. Infect Immun 70: 5148-5157.
44. Cillari E, Milano S, Dieli M, Arcoleo F, Perego R, et al. (1992) Thymopentin reduces the susceptiblity of aged mice to cutaneous leishmaniasis by modulating CD4 T cell subsets. Immunology. pp 362-366.
45. Dye C, Williams BG (1993) Malnutrition, age and the risk of parasitic disease: visceral leishmaniasis revisited. Proc Biol Sci 254: 33-39.
46. Davies CR, Mazloumi Gavgani AS (1999) Age, acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran. Parasitology 119 (Pt 3): 247-257.
47. Southgate BA, Oriedo BV (1967) Studies in the epidemiology of East African leishmaniasis. 3. Immunity as a determinant of geographical distribution. J Trop Med Hyg 70: 1-4.
48. Ben Salah A, Louzir H, Chlif S, Mokni M, Zaatour A, et al. (2005) The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis. J Infect Dis 192: 1981-1987.
49. Bucheton B, Kheir MM, El-Safi SH, Hammad A, Mergani A, et al. (2002) The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 4: 1449-1457.
50. Harms G, Fraga F, Batroff B, Oliveira F, Feldmeier H (2005) Cutaneous leishmaniasis associated with extensive lymphadenopathy during an epidemic in Ceara State, northeast Brazil Acta Trop 93: 303-310.
51. Yaghoobi-Ershadi MR, Jafari R, Hanafi-Bojd AA (2004) A new epidemic focus of zoonotic cutaneous leishmaniasis in central Iran. Ann Saudi Med 24: 98-101.
52. Yaghoobi-Ershadi MR, Hanafi-Bojd AA, Javadian E, Jafari R, Zahraei-Ramazani AR, et al. (2002) A new focus of cutaneous leishmaniasis caused by Leishmania tropica. Saudi Med J 23: 291-294.
53. Yaghoobi-Ershadi MR, Akhavan AA, Zahraei-Ramazani AV, Abai MR, Ebrahimi B, et al. (2003) Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran. East Mediterr Health J 9: 816-826.